David A Santos - Net Worth and Insider Trading

David A Santos Net Worth

The estimated net worth of David A Santos is at least $481,395 dollars as of 2024-09-21. David A Santos is the EVP, Chief Commercial Officer of Rigel Pharmaceuticals Inc and owns about 34,909 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $481,395. Details can be seen in David A Santos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Santos has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David A Santos

To

David A Santos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Santos owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of David A Santos’s form 4 insider trades.

Insider Ownership Summary of David A Santos

Ticker Comapny Transaction Date Type of Owner
RIGL Rigel Pharmaceuticals Inc 2024-02-05 EVP & Chief Commercial Officer

David A Santos Latest Holdings Summary

David A Santos currently owns a total of 1 stock. David A Santos owns 34,909 shares of Rigel Pharmaceuticals Inc (RIGL) as of February 5, 2024, with a value of $481,395.

Latest Holdings of David A Santos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2024-02-05 34,909 13.79 481,395

Holding Weightings of David A Santos


David A Santos Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Santos has made a total of 2 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 1,452 shares on February 5, 2024, which brought David A Santos around $16,552.

Insider Trading History of David A Santos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Santos Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A Santos Ownership Network

Ownership Network List of David A Santos

No Data

Ownership Network Relation of David A Santos

Insider Network Chart

David A Santos Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

David A Santos is the EVP & Chief Commercial Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & CMO Wolfgang Dummer .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, David A Santos made 1 insider transaction in Rigel Pharmaceuticals Inc (RIGL) with a net sale of 14,519. Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 12,628 shares made by Dean L Schorno ,

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

David A Santos Mailing Address

Above is the net worth, insider trading, and ownership report for David A Santos. You might contact David A Santos via mailing address: Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco Ca 94080.